Basics Savara Inc. Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases. IPO Date: March 11, 2013 Sector: Healthcare Industry: Biotech Market Cap: $1.32B Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.12% Avg Daily Range (30 D): $0.15 | 3.09% Avg Daily Range (90 D): $0.10 | 2.58% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): 2.16M Avg Daily Volume (90 D): 1.53M Trade Size Avg Trade Size (Sh.): 171 Avg Trade Size (Sh.) (30 D): 133 Avg Trade Size (Sh.) (90 D): 138 Institutional Trades Total Inst.Trades: 394 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $1.28M Avg Inst. Trade (90 D): $1.22M Avg Inst. Trade Volume: .41M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.83M Avg Closing Trade (30 D): $.92M Avg Closing Trade (90 D): $1.14M Avg Closing Volume: 449.69K     News Nov 20, 2025 @ 9:05 PM Savara Announces Participation in Upcoming Investo... Source: Business Wire Nov 7, 2025 @ 7:22 AM SVRA Investors Have Opportunity to Lead Savara Inc... Source: Prnewswire Nov 6, 2025 @ 1:57 AM SVRA DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR... Source: Rosen Law Firm Nov 3, 2025 @ 9:05 PM Savara Announces Participation in Upcoming Investo... Source: Business Wire Nov 2, 2025 @ 11:47 PM SVRA DEADLINE: ROSEN, HIGHLY RANKED INVESTOR RIGHT... Source: Rosen Law Firm Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.14 $-.12 Diluted EPS $-.14 $-.12 Revenue $ M $ $ M Gross Profit $ $ $ Net Income / Loss $ -29.56M $ -30.4M $ -26.64M Operating Income / Loss $ -30.26M $ $ -28.44M Cost of Revenue $ $ $ Net Cash Flow $ $ $ 4.46M PE Ratio     Splits Apr 28, 2017:   1:70 Apr 26, 2010:   1:25 Jul 26, 2000:   1:2